|
COMMERCE BUSINESS DAILY ISSUE OF JUNE 3,1996 PSA#1607National Cancer Institute, Research Contracts Branch, CECS, 6120
Executive Blvd, EPS/Room 620, Bethesda, MD 20892-7224 A -- ENZYME-LINKED IMMUNOASSAY OF SOLUBLE RECEPTORS, ANTIBODIES AND
IMMUNOGLOBULIN MOLECULES SOL N01-SC-71003-09 DUE 083096 POC Mary E.
Landi O'Leary, Contracting Officer, (301) 496-8611. The National Cancer
Institute (NCI) is soliciting proposals for performance of
enzyme-linked immunoassay of soluble receptors, antibodies, and
immunoglobulin molecules. An offeror must meet mandatory qualification
criteria which requires that the offeror: 1) Demonstrate how it will
accomplish the task of frequent face-to- face discussions between the
NCI Project Officer and the Contractors key personnel, to be held in
Bethesda, Maryland, in order to monitor and review progress on project
activities, 2) Demonstrate how it will accomplish the task of picking
up samples from Bethesda, Maryland, perform the assays, and provide a
written report of the results of the assays within a maximum of
twenty- four (24) hours from time of pickup, and, 3) Have
biocontainment facilities (BL-2) to conduct work in-vitro with human
and nonhuman primate viruses (such as HIV, SIV, and HTLV). The
Government anticipates one (1) award for a five (5) year contract. RFP
N01- SC-71003-09 will be issued approximately 30 days after
publication of this notice. Proposals will be due approximately 45 days
after the issue date. This procurement represents a recompetition of
N01-SC- 33036, the same project being performed by Corning-Hazleton,
Inc. Collect calls will not be accepted (0151) Loren Data Corp. http://www.ld.com (SYN# 0004 19960531\A-0004.SOL)
A - Research and Development Index Page
|
|